WK WORKIVA INC Insider Trading

CFO Jill Klindt sells 7,773 shares of WK at $67.10; stock down 41.5% from 52-week high amid unprofitability

CFO Jill Klindt sold 7,773 shares (7.8K shares) for $521,568.30, reducing her holdings by 6.7% from 115,354 to 107,581 shares. The sale occurred at $67.10 per share, a price 41.5% below the 52-week high of $114.78 and reflects recent weakness: the stock declined 8.7% over 30 days and 24.8% over 90 days. The company reported $206,280,000.00 in latest quarterly revenue with annual revenue growth of +17.2%, but is currently unprofitable with a net loss of $21,371,000.00 over its most recent full fiscal year. The combination of executive stock reduction during a period of significant stock decline and sustained operating losses creates a context that warrants monitoring, though the sale's size relative to remaining holdings remains modest.

Director RADIA SUKU V. sold 25,678 shares (47.7% of holdings) at $95.00; WK unprofitable despite +17.1% annual revenue growth.

RADIA SUKU V. sold 25,678 shares, reducing holdings by 47.7% from 53,832 to 28,154 shares. The sale occurred at $95.00 per share for a total of $2,439,410.00, at a time when the current stock price is $94.41 and the stock has risen +18.2% over 30 days and +18.9% over 90 days, now trading 9.6% below its 52-week high of $104.40. The company generated $185,621,000.00 in latest-quarter revenue with +17.1% annual revenue growth but posted a full-year net loss of $16,992,000.00, indicating profitability remains elusive despite strong top-line expansion. The substantial reduction in a director's stake warrants investor attention to the specific timing and motivations underlying the disposition.

Director Martin Vanderploeg purchases 4,000 WK shares ($280.2K) in 2 transactions at $69.85–$70.81 on 2024-09-11

Vanderploeg executed two separate open-market purchases totaling 4,000 shares (4.0K shares) for $280,242.88 at a blended average price of $70.06, increasing his holdings from 341,869 to 345,869 shares. The transactions occurred at prices near the 52-week low of $70.22, and the stock currently trades at $74.73, approximately -33.6% from its 52-week high of $112.52. However, his prior trades at WK show mixed near-term returns: the two August 2024 purchases each posted negative 30-day returns (-2.5% and -3.3%), and his cross-ticker track record shows an average 30-day return of -2.9% across 3 prior buys. Notably, none of his prior buys have yet posted a positive 90-day return, and the company remains unprofitable (full-year net income was negative) despite +17.1% annual revenue growth.

Director VANDERPLOEG MARTIN J. purchases 4,000 shares of WK at $78.91; stock now -29.5% from 52-week high amid unprofitable operations.

VANDERPLOEG acquired 4,000 shares of WK on 2024-08-16 at $78.91, following another purchase exactly one week prior on 2024-08-09. This buy brings his stake to 341,869 shares (341.9K shares), a +1.2% increase. The company is currently unprofitable (net income $-17.5M in latest quarter; full-year net income negative) despite solid revenue growth of +17.1% year-over-year and quarterly revenue of $177.5M. The stock trades at $79.34 today, down 29.5% from its 52-week high of $112.52, though it has recovered +10.1% over the past 30 days. His prior trades at WK have not yet reached the 90-day measurement threshold. The pattern of consecutive week buys in a depressed valuation context warrants attention to whether management has visibility into near-term profitability improvement.

Director Martin Vanderploeg bought 4,000 shares of WK at blended $74.99 (2 transactions); holds 337.9K shares post-trade.

Martin Vanderploeg, Director at Workiva, executed 2 purchases totaling 4,000 shares for $299,954.30 at a blended average price of $74.99 on 2024-08-09. The transaction occurred while Workiva's stock is down 32.2% from its 52-week high of $112.52, and the company remains unprofitable with a net loss of $17.5M in its latest quarter despite 17.1% annual revenue growth. The $300.0K purchase expanded his holdings by 1.2%, modestly increasing his stake in a company undergoing operational challenges. This modest accumulation at depressed price levels adds limited directional insight without additional context on whether this is a scheduled or discretionary action.